How have QNCX shares performed in 2024?

Quince Therapeutics' stock was trading at $1.05 at the start of the year. Since then, QNCX stock has increased by 1.0% and is now trading at $1.06. View the best growth stocks for 2024 here .

When is Quince Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our QNCX earnings forecast .

How do I buy shares of Quince Therapeutics?

Shares of QNCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:QNCX

Quince Therapeutics (QNCX) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free QNCX Stock Alerts

$1.06

+0.06 (+6.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.98
▼
$1.07
50-Day Range: $0.94
▼
$1.35
52-Week Range: $0.84
▼
$1.74

Volume: 80,573 shs
Average Volume: 75,629 shs
Market Capitalization: $45.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Quince Therapeutics alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About Quince Therapeutics Stock (NASDAQ:QNCX)

Quince Therapeutics, Inc., a preclinical stage biopharmaceutical company, develops precision therapeutics for debilitating and rare diseases. Its lead compound is NOV004, a systemically administered bone anabolic peptide engineered to target and concentrate at bone fracture sites. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

QNCX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

QNCX Stock News Headlines

April 12, 2024 | americanbankingnews.com

Quince Therapeutics (NASDAQ:QNCX) Trading 1% Higher

April 2, 2024 | investorplace.com

QNCX Stock Earnings: Quince Therapeutics Reported Results for Q4 2023

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 1, 2024 | finance.yahoo.com

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

February 22, 2024 | finance.yahoo.com

Quince Therapeutics Launches Scientific Advisory Board

February 22, 2024 | businesswire.com

Quince Therapeutics Launches Scientific Advisory Board

February 15, 2024 | finance.yahoo.com

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

February 15, 2024 | businesswire.com

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 4, 2024 | finance.yahoo.com

Quince Therapeutics to Participate at Investor Events in January 2024

November 11, 2023 | morningstar.com

Quince Therapeutics Inc QNCX

October 27, 2023 | benzinga.com

Chief Business Officer and COO at Quince Therapeutics Acquires Company Stock Options Worth 75,000 Shares

October 25, 2023 | benzinga.com

Quince Therapeutics Chief Scientific Officer Awarded $291K Worth of Stock Options

October 23, 2023 | finance.yahoo.com

Quince Therapeutics Completes Acquisition of EryDel S.p.A.

September 28, 2023 | msn.com

FDA lifts partial clinical hold on EryDel lead product EryDex

September 28, 2023 | finance.yahoo.com

U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia

September 7, 2023 | benzinga.com

Quince Therapeutics President Awarded $692K Worth of Stock Options

September 6, 2023 | bizjournals.com

Daily Digest: Currys aim to raise $50M for Oakland schools; Sotheby's opens new office

September 6, 2023 | finance.yahoo.com

Quince Therapeutics Appoints Dr. Charles S. Ryan as President

August 18, 2023 | benzinga.com

325K Reasons To Be Bullish On Quince Therapeutics Stock

August 14, 2023 | benzinga.com

Quince Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying

August 11, 2023 | finance.yahoo.com

Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023

July 26, 2023 | finanznachrichten.de

QUINCE THERAPEUTICS INC

July 24, 2023 | benzinga.com

What's Going On With Quince Therapeutics Stock Today

July 24, 2023 | finance.yahoo.com

Quince Therapeutics to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity

July 13, 2023 | msn.com

Echo Lake bumps up bid to buy Quince Therapeutics to $1.80

July 13, 2023 | seekingalpha.com

Echo Lake bumps up bid to buy Quince Therapeutics to $1.80/share

See More Headlines

Receive QNCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:QNCX
CUSIP: N/A
CIK: 1662774
Web: www.quincetx.com
Phone: (650) 910-5717
Fax: N/A
Employees: 32
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.84)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-31,390,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -36.36%
Return on Assets: -28.83%

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 8.09
Quick Ratio: 8.09

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.98 per share
Price / Book: 0.54

Miscellaneous

Outstanding Shares: 43,215,000
Free Float: 34,140,000
Market Cap: $45.81 million
Optionable: Optionable
Beta: 1.25

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Dr. Dirk Thye M.D. (Age 54)
CEO & Director
Comp: $681.36k
Mr. Brendan Hannah M.B.A. (Age 38)
Principal Financial Officer, Principal Accounting Officer, Chief Business Officer & COO
Comp: $504.34k
Dr. Charles S. Ryan J.D. (Age 60)
Ph.D., President
Dr. Guenter R. Janhofer M.D.
Ph.D., Chief Scientific Officer
Ms. Stacy Roughan
Vice President of Corporate Communications & Investor Relations
Ms. Mary Ellen Sillivos
Vice President of Human Resources
Dr. Stewart A. Low Ph.D.
Head of Discovery

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

QNCX Stock Analysis - Frequently Asked Questions

How have QNCX shares performed in 2024?: Quince Therapeutics' stock was trading at $1.05 at the start of the year. Since then, QNCX stock has increased by 1.0% and is now trading at $1.06.
View the best growth stocks for 2024 here.
When is Quince Therapeutics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our QNCX earnings forecast.
How do I buy shares of Quince Therapeutics?: Shares of QNCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:QNCX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial